The Canbex Therapeutics brand, founded in 2005 (United Kingdom), from 306 sister brands and 4958 competing brands. Canbex Therapeutics is a brand of Ipsen, listed on the stock exchange of Paris. The International Securities Identification Number (ISIN) of Ipsen is FR0010259150. Canbex Therapeutics is part of the Drug Manufacturers activity sector.
Share price and profitability of the share Ipsen (Canbex Therapeutics)
Buy Ipsen share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
Ipsen
(Canbex Therapeutics)
over 5 years*
EUR 111.55
Stock market history Ipsen (Canbex Therapeutics)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
